This topic contains a solution. Click here to go to the answer

Author Question: Why is PIP challenging? A) Because it is expensive B) Because only systems analysts participate ... (Read 57 times)

ap345

  • Hero Member
  • *****
  • Posts: 537
Why is PIP challenging?
 
  A) Because it is expensive
  B) Because only systems analysts participate in the process
  C) Because it is a closed-ended process
  D) Because it turns a vague system request into a project description

Question 2

Which of the following is NOT a criticism of the traditional waterfall SDLC approach?
 
  A) Prototypes do not work properly.
  B) Users are locked into requirements.
  C) The role of customers is narrowly defined.
  D) Intangible processes are given hard and fast dates.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

prumorgan

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

D

Answer to Question 2

A




ap345

  • Member
  • Posts: 537
Reply 2 on: Jul 7, 2018
Wow, this really help


flexer1n1

  • Member
  • Posts: 373
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Never take aspirin without food because it is likely to irritate your stomach. Never give aspirin to children under age 12. Overdoses of aspirin have the potential to cause deafness.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library